Chemomab Therapeutics Ltd. ( CMMB) - Stock Earnings
CMMB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.9 million USD | — USD |
| 2026Q1 | -1.8 million USD | — USD |
| 2026Q2 | -2.2 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
CMMB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -24.2 million USD | — USD |
| 2024 | -13.9 million USD | — USD |
| 2025 | -9.0 million USD | — USD |
| 2026 Est. | — | — |
CMMB
Price: $2.58
52 week price:
Earnings Per Share: -1.05 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 37000
Market Capitalization: 17.4 million